NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News $1.66 -0.03 (-1.78%) (As of 09/20/2023 ET) Add Compare Share Share Today's Range$1.63▼$1.7450-Day Range$1.64▼$2.0652-Week Range$1.62▼$3.24Volume90,816 shsAverage Volume26,079 shsMarket Capitalization$6.57 millionAssets Under Management$6.36 millionDividend Yield3.01%Net Expense Ratio1.00% ProfileProfileChartHeadlinesHoldingsRatingsProfileChartHeadlinesHoldingsRatings About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL)The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.Read More PSIL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PSIL ETF News HeadlinesSeptember 16, 2023 | americanbankingnews.comAdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Price Down 0.6%September 11, 2023 | markets.businessinsider.comPsyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And MoreSeptember 21, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.August 21, 2023 | benzinga.comPsyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly ReportsJuly 24, 2023 | benzinga.comPsyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & MoreJuly 15, 2023 | msn.comWatch these psychedelic stocks as sector faces year of 'collapse and consolidation'July 11, 2023 | markets.businessinsider.comPsyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And MoreMay 15, 2023 | markets.businessinsider.comPsyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & MoreSeptember 21, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.April 27, 2023 | thestreet.comAre There Too Many ETFs?See More Headlines Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings23 Fund Statistics Assets Under Management$6.36 million Average Daily Volume$0.00 Discount/Premium0.07% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume3 Put Options1 Call Options2 Miscellaneous Outstanding Shares3,960,000Beta0.93 Creation Fee$500.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.53%0.50%0.50%Other Expenses2.51%0.78%0.52%0.64%0.57%Total Expense3.11%0.73%0.69%0.74%0.69%Fee Waiver-2.11%-0.80%-0.55%-0.70%-0.59%Net Expense1.00%0.60%0.59%0.57%0.57% AdvisorShares Psychedelics ETF (PSIL) Holdings & ExposureTop 10 PSIL HoldingsCybin Inc Ordinary SharesHolding Weight: 12.22%COMPASS Pathways(NASDAQ:CMPS)Holding Weight: 11.57%GH Research(NASDAQ:GHRS)Holding Weight: 8.14%Mind Medicine (MindMed)(NASDAQ:MNMD)Holding Weight: 7.16%Alkermes(NASDAQ:ALKS)Holding Weight: 6.42%Seelos Therapeutics(NASDAQ:SEEL)Holding Weight: 5.70%Bright Minds Biosciences Inc Ordinary SharesHolding Weight: 5.41%Relmada Therapeutics(NASDAQ:RLMD)Holding Weight: 5.18%Lucy Scientific Discovery(NASDAQ:LSDI)Holding Weight: 4.84%Atai Life Sciences(NASDAQ:ATAI)Holding Weight: 4.71%PSIL Sector ExposurePSIL Industry ExposureFull Holdings Details Similar ETFsiShares MSCI China Multisector Tech ETFNASDAQ:TCHIWisdomTree India ex-State-Owned Enterprises FundNYSEARCA:IXSEETFB Green SRI REITs ETFNYSEARCA:RITAGlobal X Solar ETFNASDAQ:RAYSSoFi Be Your Own Boss ETFNASDAQ:BYOB PSIL ETF - Frequently Asked Questions How have PSIL shares performed in 2023? AdvisorShares Psychedelics ETF's stock was trading at $1.86 at the start of the year. Since then, PSIL stock has decreased by 10.8% and is now trading at $1.6599. View the best growth stocks for 2023 here. What does PSIL invest in? AdvisorShares Psychedelics ETF is a equity fund issued by AdvisorShares. PSIL focuses on theme investments. The fund's investments total to approximately $6.36 million assets under management. What stocks does AdvisorShares Psychedelics ETF hold? PSIL invests in 23 holdings. Some of the stocks in their portfolio include COMPASS Pathways (CMPS), GH Research (GHRS), Mind Medicine (MindMed) (MNMD), Alkermes (ALKS), Seelos Therapeutics (SEEL), Relmada Therapeutics (RLMD), Lucy Scientific Discovery (LSDI), Atai Life Sciences (ATAI), Intra-Cellular Therapies (ITCI) and Enveric Biosciences (ENVB). What is the management fee for AdvisorShares Psychedelics ETF? AdvisorShares Psychedelics ETF's management fee is 0.60% and has other expenses of 2.51%. However, PSIL has a fee waiver of -2.11% to reimburse the expenses. The net expense ratio for PSIL is 1.00%. What is AdvisorShares Psychedelics ETF's stock symbol? AdvisorShares Psychedelics ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PSIL." How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is AdvisorShares Psychedelics ETF's stock price today? One share of PSIL stock can currently be purchased for approximately $1.66. How much money does AdvisorShares Psychedelics ETF make? AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) has a market capitalization of $6.57 million. This page (NYSEARCA:PSIL) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.